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Abstract 
 
 
Intestinal apoptosis and expression of apoptosis inducers – the cytokines TNFα, TGFβ1 – and 
the intestinal transcription factor Cdx2, were studied according to two different metabolic and 
hormonal phases which characterize long-term fasting: the long period of protein sparing 
during which energy expenditure is derived from lipid oxidation (phase II), and the later phase 
characterized by a rise in body protein utilization and plasma corticosterone (phase III). 
Apoptosis was further studied in 2, 6 and 24h refed rats. Morphological apoptotic events were 
observed by environmental and conventional scanning electron microscopy and TUNEL test 
was used to characterize the final stages of apoptotic death. The gene and protein expressions 
of TNFα, TGFβ1, and Cdx2 were measured. Apoptotic events and TNFα, TGFβ1, and Cdx2 
gene and protein expressions did not vary significantly during phase II compared to normally-
fed animals. However, phase III fasting induced a delay in intestinal epithelial apoptosis, 
along with a 92%, 58% and 25% decrease in TNFα, TGFβ1 and Cdx2 mRNAs, respectively. 
The amounts of TNFα, TGFβ1 and Cdx2 proteins decreased by 70%, 36% and 25%, 
respectively. Apoptosis was restored rapidly after 2h refeeding following phase III, 
accompanied by a significant increase in TNFα, TGFβ1 and Cdx2 mRNA and protein levels, 
compared to the phase III fasting values. The concomitant decreases in cytokines and Cdx2 
and in apoptotic cells during phase III suggest the preservation of enterocytes during this 
critical fasting period in order to optimize nutrient absorption as soon as food is available and 
thus, to rapidly restore body mass. 
 
Keywords: apoptosis, body reserves depletion, corticosterone, cytokines. 
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Introduction 
 
Three distinct metabolic phases have been described during a fast (7, 21, 30, 32). During the 
first phase (phase I), glycogen stores are completely exhausted and fat stores are progressively 
used. This phase lasts only a few hours in rats. The second phase (phase II) corresponds to a 
phase of economy with the mobilization of fat stores for energy expenditure whereas body 
proteins are efficiently spared. The third phase (phase III) is characterized by an increasing 
protein catabolism caused by a rise in plasma corticosterone levels. During this later phase, 
there is a clear change in behavior which promotes food foraging, therefore anticipating a 
lethal depletion of energy stores (30). In rats, fasting during either phase II or phase III 
induces a significant decrease in the size of intestinal villi and thus, in the small intestinal 
mass (13). Also, during the phase of protein sparing (phase II), cell proliferation in crypts and 
cell migration along the crypt-villus axis decrease, whereas apoptosis at the tip of the villi is 
maintained (22). In phase III however, when the rat has reached a critical threshold in body 
reserves utilization, intestinal cell proliferation and migration increase significantly compared 
to phase II fasted and normally-fed rats. In parallel, we observed a delay in apoptotic events at 
the tip of the villi (22). The increase in cell proliferation and the preservation of absorptive 
cells are concomitant with a rise in locomotor activity reflecting the search for food (30) and 
may prepare the mucosa to nutrient absorption as soon as food is available. The aim of the 
current work is to further evaluate the intestinal apoptotic changes linked to the metabolic 
state of fasted rats. 
During the normal course of the development of the animal, apoptosis is activated as a 
response to specific endogenous factors such as TNFα and TGFβ1 (15, 36); the caudal-related 
homeodomain protein Cdx2 has also been shown to be critical in these processes (3). 
Apoptosis can be induced by exposure to cytotoxic compounds, hypoxia, viral infection, 
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changing levels of specific hormones, and fasting. A short period of starvation (less than 3 
days) has been shown to increase apoptosis in the small intestine mucosa (19, 27, 28). 
However, other authors (34) have related a decrease in apoptosis following a 3-day starvation 
period. The effects of longer periods of fasting and of refeeding on apoptotic events in the 
small intestine remain almost unknown and intestinal apoptosis has never been studied by 
other authors in relation to whole body metabolism.  
In this study, we evaluate the effects of phase II and phase III fasting and of refeeding on 
apoptotic events in the intestinal epithelium. Apoptosis was studied at the level of cell 
morphology by Scanning Electron Microscopy (SEM), and cell biology using the TUNEL 
test. The concomitant variations of proapoptotic cytokines (TNFα, TGFβ1) and of the 
intestine specific transcription factor Cdx2 were analyzed by RT-PCR in order to determine 
gene expressions, and by western blot in order to quantify TNFα, TGFβ1 and Cdx2 protein 
levels. Finally, TGFβ1 and Cdx2 protein distribution along the crypt-villus axis was 
investigated by immunohistochemical detection.  
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Materials and methods 
 
Animals 
Male Wistar rats weighing 350g were obtained from Iffa-Credo (Lyon, France). The animals 
were housed individually in leucite cages with a wire mesh floor to minimize coprophagia, 
and were maintained at 23°C with a 12-hour light period. They had free access to the control 
diet (A03 pellets from UAR, Epinay-sur-Orge, France) consisting of 23% (by mass) protein, 
51.1% carbohydrates, 4.3% fat, 4% cellulose, 5.6% minerals, and 12% water. The rats had 
free access to water throughout the experiments. They were weighed every day between 9.00 
and 10.00 a.m. Our experimental protocol followed the Centre National de la Recherche 
Scientifique (CNRS) guide for care and use of laboratory animals. 
 
Experimental procedures 
After a one week acclimatization, normally-fed rats served as control animals (Ctrl, n=15), 
whereas the other rats were food-deprived. The fasting phases were determined by calculating 
the specific daily rate of body mass loss dM/Mdt (g/kg/day) for each animal (dM represents 
the loss of body mass during dt=t B1 B-tB0 B and M is the rat body mass at t B0B). This calculation 
permitted a daily monitoring of the physiological status for each animal through fasting. With 
this monitoring, all the animals survived the prolonged starvation procedure and could be 
successfully refed. The first fasting phase (phase I) lasted only a few hours and was 
characterized by a rapid decrease in dM/Mdt. The specific daily body mass loss then reached 
a steady rate (approximately 55g/kg/day) representing phase II and finally, strongly increased 
which was characteristic of phase III. 
The phase II fasting period lasting between one and six days (for 350g rats), a first group of 
rats was killed in the fourth day in phase II (P2r0, n=15). Three other groups were refed 
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during 2h (P2r2, n=5), 6h (P2r6, n=5), or 24h (P2r24, n=5) following phase II, and then 
killed. Four additional groups continued fasting until the second day of phase III, reaching on 
average eight days of fasting. One group was killed in phase III without refeeding (P3r0, 
n=15), whereas the three others were killed after refeeding for 2h (P3r2, n=5), 6h (P3r6, n=5), 
or 24h (P3r24, n=5) following phase III.  
The animals were killed between 9.00 and 10.00 a.m. The jejunum was removed, weighed, 
and cut into segments. These segments were then treated separately depending on the analysis 
considered (CSEM, ESEM, immunohistochemistry, RT-PCR, western blotting). 
 
Plasma parameters 
Blood samples were collected immediately after sacrifice to measure plasma concentrations of 
urea and corticosterone in all experimental groups. To assess the metabolic state for each 
animal, plasma urea was determined with a Urea Nitrogen Kit (Sigma Diagnostics, St Louis, 
USA), according to the manufacture's guidelines. The plasma concentration of corticosterone 
was determined with an Enzyme Immunoassay Kit (Assay Designs Inc., Ann Arbor, USA). 
 
Environmental Scanning Electron Microscopy 
Samples of jejunal mucosa were placed in 1% glutaraldehyde and buffered saline for 30s to 
block mucus secretion, and then viewed with a Philips XL-30 ESEM. The pressure in the 
sample chamber was maintained at 5 Torr and the temperature at 4°C, in order to hold a 
relative humidity rate of 80% at the sample surface. 
 
Conventional Scanning Electron Microscopy 
Jejunal mucosal samples were fixed for 2h at 4°C in 5% glutaraldehyde in 0.05M cacodylate 
buffer (pH=7.4), post-fixed 1h in 1% osmium tetroxide, and dehydrated. Pieces were then 
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dried with hexamethyldisilazane. After being mounted on stubs, samples were coated with 
gold and examined with a Philips XL-30 ESEM. 
 
TUNEL assay procedure 
The TUNEL assay (in situ Cell Death Detection Kit, fluorescein) was performed according to 
the manufacturer's specifications (Roche, USA). Each experiment set up by TUNEL reaction 
mixture without terminal transferase served as negative control. Samples pre-treated with 
DNAse (2mg/mL) served as positive controls. Sections were examined with a fluorescent 
microscope (Zeiss Axioplan) equipped with the appropriate filter set (450-590nm bandpass 
excitation filter). TUNEL-positive cells with fully condensed nuclei were counted in a 
minimum of 30 villus sections per animal and in 5 animals per group and expressed as a 
percentage of the total epithelial cells. 
 
RT-PCR analysis 
Total RNA from jejunal mucosa was extracted by the method of Chomczynski and Sacchi (8). 
cDNA was synthesized from 2µg total RNA in 25µL reaction buffer (Finnzymes OY, 
Finland) containing 1µL of avian myeloblastosis virus reverse transcriptase (Finnzymes OY, 
Finland), oligo(dT)B17 B primer (50pM, Eurogentec, Belgium) and 0.2mM of deoxynucleotide 
triphosphate (Promega, France), (60min at 42°C). cDNA was then amplified by Polymerase 
Chain Reaction (PCR) using specific primers (Table I). The PCR reactions were carried out in 
10µL Red’Y’StarMix (Eurogentec, Belgium) diluted to a final volume of 20µL, 50pM of each 
primer and 1µL of the cDNA mixture. cDNAs were amplified for a determined number of 
cycles (Table I) as follows: hot starting for 10min at 95°C, denaturation for 45s at 94°C, 
annealing at 50°C for 45s, and elongation at 72°C for 45s. PCR products were resolved on a 
Table I 
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3% agarose gel and visualized by ethidium bromide staining. The staining intensity was 
evaluated using the Molecular Analyst software (Bio-Rad Laboratories, USA). Results were 
expressed as relative densitometric units, normalized to the values of a phosphoribosomal 
protein mRNA used as internal control. 
 
Western blotting and immunohistochemistry 
Western blotting and immunohistochemistry were conducted as described previously (23). 
The primary antibodies used were polyclonal rabbit anti-rat TGFβ1 [anti-LC-(1-30)] 
(generously provided by Dr. K. C. Flanders), monoclonal mouse anti-human Cdx2 
(BioGenex, San Ramon, Ca, USA) and polyclonal rabbit anti-human TNFα (Genzyme 
Diagnostics, Cambridge, USA). 
Cdx2 antibody could be detected on paraffin sections after incubation with Alexa B488B-
conjugated goat anti-mouse IgG (Molecular Probes), whereas TGFβ1 immunolocalization 
was performed using the standard extravidin-biotin-peroxidase complex technique and 
diamino-benzidine coloration. 
 
Statistical analysis 
Data are presented as mean values +/- SEM. Statistical comparisons of experimental data 
were performed by one-way analysis of variance (ANOVA) and Tukey post-hoc test by using 
the software Sigmastat (Jandel). The level of statistical significance was set at P<0.05. 
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Results 
 
Evolution of the metabolic and hormonal status  
Plasma urea concentration (Table II) did not vary between control, phase II fasted rats and 
refed rats following phase II. A phase III fast induced a 3.7-fold significant increase in urea 
concentration. Uremia then decreased in rats after 6h refeeding following phase III. 
Plasma corticosterone concentration (Table II) showed a 13-fold increase in P2r0 fasted 
animals compared to controls, but it was not significant. After refeeding following a phase II 
fasting period, plasma corticosterone concentration was lower compared to control values. In 
phase III fasted rats, plasma corticosterone concentration exhibited a 370-fold significant 
increase compared to controls, and a 29-fold increase compared to P2r0 fasted rats. Refeeding 
following phase III induced a rapid decrease in plasma corticosterone. 
 
Apoptotic events 
Environmental Scanning Electron Microscopy makes it possible to examine fresh, lightly 
fixed biological specimens (neither dehydrated, nor gold coated) without artifacts linked to 
sample manipulation and treatment. A morphological study of apoptotic events at the tip of 
the villi was therefore possible for our 9 experimental groups (figure 1, a to i). These 
observations were made along the jejunum for 5 animals per group. Apoptotic zones were 
observed at the villi tips in control (figure 1a) and phase II fasted rats (figure 1b), but very few 
apoptotic events could be seen in phase III fasted rats (figure 1c) and in rats refed 2 and 6h 
following phase II (figure 1, d and e). In animals refed 24h following phase II (figure 1f), and 
in those refed following phase III (figure 1, g to i), the intestinal villi tips looked like those in 
controls. Observations made at higher magnifications with Conventional Scanning Electron 
Microscopy (figure 1, j to l) showed apoptotic cells being extruded from the epithelium and 
Table II 
Figure 1 
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losing their microvilli in control (figure 1j) and in phase II fasted rats (figure 1k) but not in 
phase III fasted rats (figure 1l).  
There were no differences in the number of TUNEL-positive cells at the tips of the villi 
between control and phase II fasted rats (figure 2, a, b and j). Only a few apoptotic cells could 
be seen in animals refed 2h and 6h after a phase II fast (figure 2, d, e and j). Numerous 
TUNEL-positive cells could be seen again after 24h refeeding following phase II (figure 2f 
and j). In phase III, almost no apoptotic cells could be detected at the tip of intestinal villi 
(figure 2c and j). However, after refeeding following phase III, the apoptotic index was the 
same as in control animals (figure 2, g to j). 
 
Changes in TNFα and TGFβ1 gene and protein expressions  
TNFα and TGFβ1 were expressed in the small intestine mucosa (figures 3 and 4). However, 
TNFα was only faintly expressed, as indicated by the high number of PCR cycles needed to 
detect its mRNA (Table I).  
TNFα transcripts and protein level (figure 3A and B) did not vary during a phase II fast 
compared to control animals. However, TNFα mRNA levels were very low in animals refed 
2h and 6h after phase II compared to controls and phase II fasted rats, but no significant 
difference in the amounts of TNFα protein could be detected. A phase III fast strongly 
reduced TNFα gene expression and protein level. After 2h refeeding following phase III, the 
amount of TNFα mRNA exhibited a 7.5-fold increase compared to the control value, and a 
94-fold increase compared to the phase III value. It then decreased during 6h and 24h 
refeeding following phase III, but was still higher than in control rats. TNFα protein level 
rose to control value after only 2h refeeding following phase III.  
TGFβ1 (figure 4A and B) gene expression and protein level did not vary during a phase II fast 
compared to controls, but a significant increase was observed between animals refed 2h 
Figure 2 
Figure 3 
Figure 4 
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following phase II and control and phase II fasted animals. TGFβ1 gene expression and 
protein level were then lowered to control values in 6h and 24h refed rats following phase II. 
During phase III fasting, TGFβ1 mRNA level and protein amount were decreased by 58% and 
36%, respectively. After refeeding following phase III, TGFβ1 gene expression and protein 
level increased and rapidly reached the control values. 
TGFβ1 was localized in the cytoplasm of intestinal epithelial cells, and particularly in the 
apical part of the enterocytes (figure 4C). It was observed in the upper third of the intestinal 
villi in control and refed rats, but was weakly expressed in phase III fasted rats. 
 
Modulations of Cdx2 expression and localization 
Cdx2 gene expression and protein level (figure 5A and B) did not change during a phase II 
fast. However, a significant increase was observed after 2h refeeding following phase II. After 
6h refeeding, Cdx2 gene expression and protein level were then lowered to control values. A 
phase III fast induced a 25% decrease in Cdx2 mRNA level and protein amount. After 
refeeding following phase III, Cdx2 gene expression and protein level increased and rapidly 
reached the control values. 
Cdx2 was localized in the nuclei of intestinal cells and showed a decreasing gradient along the 
crypt-villus axis (figure 5C). A decrease in the expression of Cdx2 protein was observed in 
phase III fasted animals compared to controls. The number of strongly labeled nuclei 
increased in animals refed 2h following either phase II, mainly in the crypt compartment, or 
phase III, all over the crypt to villus axis.  
 
 
 
 
Figure 5 
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Discussion 
 
This study provides evidence that the different apoptotic events described in the small 
intestinal epithelium during fasting and refeeding appear concomitantly with the different 
metabolic states of prolonged fasting. During phase II fasting, i.e. when the energy 
requirements are mostly derived from lipid oxidation, changes in intestinal villus cell 
apoptosis are not obvious compared to normally-fed animals. However, a phase III fast 
characterized by an increase in protein utilization as a substitute fuel for lipids, induces a 
down-regulation of apoptotic events accompanied by significant modifications in the 
expression of the proapoptotic cytokines TNFα and TGFβ1 and of the intestinal specific 
transcription factor Cdx2. Whereas refeeding after phase II induces a reduction in apoptosis, 
refeeding following phase III rapidly restores apoptosis at the villi tips with TNFα, TGFβ1 
and Cdx2 expression, also rapidly normalized. In a previous work (22), we also demonstrated 
that crypt cell proliferation and migration were decreased during a phase II fast and 
extensively increased during phase III. All together, these changes could correspond to the 
preparation of a physiologically functional epithelium able to digest and absorb nutrients at 
refeeding.  
 
We clearly demonstrate a difference in the occurrence of apoptotic events in the intestinal 
mucosa according to the different metabolic phases through fasting. During the phase of lipid 
oxidation (phase II), apoptosis was observed at the villus tips with the same frequency as in 
normally-fed animals. In phase III however, when the depletion in lipid reserves has reached 
about 80% of the initial stores, no apoptotic cells were observed at the tips of the villi. This 
may explain the conflicting results obtained in previous studies. Apoptosis appeared to 
increase after a very short (1-day) starvation period (27). Because of such a small fasting 
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duration, the rats used in this study and weighing 250-300g were most probably in a phase of 
lipid oxidation (phase II). During a longer starvation period (3 days), data obtained in younger 
rats (200-250g) with less adiposity showed on the contrary, a down-regulation of DNA 
fragmentation (34). These animals may not have been in the same hormonal and metabolic 
state as in the Iwakiri’s study (27), and were likely to be in a phase of protein catabolism 
(phase III).  
From these data, it appeared necessary to further evaluate the effects of phase II and phase III 
starvation periods on early apoptotic inducers and particularly on TNFα, TGFβ1, and Cdx2, 
normally present in the gastrointestinal mucosa. TNFα is a cytokine involved in enterocyte 
apoptosis; mice treated with TNFα show marked villus atrophy (37). High doses of TNFα 
have been shown to inhibit cell growth, whereas TNFα at low doses promotes epithelial cell 
proliferation (10, 15, 25, 29, 43). This cytokine is secreted in the intestinal mucosa by 
immune competent cells present in the lamina propria, by intraepithelial lymphocytes (16) 
and also by enterocytes (39). The decrease in TNFα protein during phase III may induce the 
delay in enterocyte apoptosis at the tip of the villi thus preventing the intestinal mucosa from 
further degradation during long-term fasting. In addition, the decrease in TNFα may also 
favor the increase in crypt cell proliferation previously observed in phase III (22). By its 
effects on both apoptosis and proliferation, TNFα may contribute to the preservation of the 
mucosal integrity during phase III. The observed increase in TNFα gene and protein levels 2h 
after refeeding following phase III, may explain the restoration of epithelial apoptosis.  
TGFβ1 is a multipotent cytokine playing an important role in regulating intestinal epithelial 
cell growth and differentiation (35, 38). It is an inhibitor of crypt cell proliferation (1, 31) and 
has a proapoptotic role by regulating gene transcription of proteins associated with apoptosis 
such as Bcl-2 family members (24). In our study, TGFβ1 gene and protein expressions did not 
vary during the phase II fast. This result is in accordance with the absence of modifications in 
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apoptotic events during a phase II fast. However, despite the marked drop in villus apoptosis 
after 2h refeeding following phase II, a rapid increase in TGFβ1 mRNA level and protein 
expression was observed. The proapoptotic effect of TGFβ1 may be blocked by the increase 
in plasma insulin level (6) occurring after refeeding following phase II (23). In our previous 
study (22), we demonstrated that refeeding after a phase II fast induces a rapid restoration of 
villus morphology. At this stage, TGFβ1 could stimulate mucosal repair by increasing 
extracellular matrix protein synthesis (26), and epithelial cell restitution (9, 11). A similar 
increase in the gene expression of TGFβ1 has also been reported in aberrant crypt foci and in 
the surrounding mucosa of refed rats (4). The severe decrease in TGFβ1 gene and protein 
expressions and the faint epithelial labeling observed in phase III fasting animals could partly 
explain the disappearance of intestinal apoptotic cells and the increase in crypt cell 
proliferation (DNA synthesis and mitosis) occurring during this metabolic phase. TGFβ1 
mRNA level and protein expression returned to control value after only 2h refeeding 
following a phase III and was accompanied by the rapid restoration of apoptotic events.  
The homeobox gene Cdx2 is known to reduce intestinal cell proliferation, and to stimulate 
cell differentiation and apoptosis (12, 18, 33, 41, 42). To our knowledge, the effects of short-
term and prolonged fasting on Cdx2 in vivo are still scanty. Only one study indicates a 
decrease in Cdx expression in 48h fasted chicks (20). Our results show that Cdx2 is located in 
the nuclei of crypt cells and of differentiating enterocytes with a decreasing crypt-villus 
gradient. The amount of Cdx2 protein decreased during the phase III fast and the crypt-villus 
gradient became barely detectable. This suggests that the absence of Cdx2 in epithelial cells 
from the villi tips may be involved in the downregulation of apoptosis during phase III and its 
faint expression in crypt cells may favor the increase in cell proliferation previously observed 
during this fasting phase (22).  
Most of the changes occurring during the phase III fasting period could be linked to the strong 
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increase in plasma corticosterone (this study, 2) concomitant to the decrease in cytokine 
expression in the jejunum, the increased cell proliferation rate in intestinal crypts and the 
arrest in apoptotic events at the villi tips. In an early study, the role of glucocorticoids on 
cytokines secretion was pinpointed as injection of glucocorticoids in vivo induced a decrease 
in TGFβ1 gene expression (40). Glucocorticoids also, negatively regulate TNFα expression in 
cultured myofibroblats isolated from the jejunum (40) and suppress TNFα secretion by 
human lamina propria lymphocytes (14). Finally, it has been shown that adrenalectomy leads 
to partial atrophy and disorganization of the villi architecture, associated with a decrease in 
crypt cell proliferation, and an increase in apoptotic cells at the tip of the villi (17).  
Therefore, in light of the data presented here, one can hypothesize that the levels of energy 
depletion reached by fasting animals are involved in the occurrence of apoptosis in intestinal 
villi through fasting and after refeeding. The down-regulation of apoptosis during phase III 
must preserve differentiated epithelial cells and seems strongly correlated with the decreased 
expression of the homeoprotein Cdx2 and cytokines TNFα and TGFβ1. These changes may 
lead to the already observed increased cell proliferation rate inducing mucosal repair during 
the phase III fast, before food becomes available (22). Preservation of absorptive cells and 
initiation of cell proliferation during phase III fasting is concomitant with a peak of locomotor 
activity in these animals induced by a rise in plasma corticosterone and reflecting the search 
for food (5, 30). The unaltered absorption capabilities of the intestine could then permit rapid 
food assimilation immediately after refeeding and thus, the restoration of the whole body 
condition. This could be crucial for surviving prolonged fasting, since animals entering phase 
III, have reached a critical depletion level in their lipid reserves and body proteins. 
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Table I: 
 
 
Synthetic oligonucleotides and experimental conditions used in reverse transcription-
polymerase chain reaction analysis 
 
Gene Position Size 
(bp) 
Sequence Cycling 
number 
Ribosomal 
phosphoprotein 
340-360 
847-828 
486 5’-GTTCACCAAGGAGGACCTCA-3’ 
3’-AGACACCTCTGCCTAATGTG-3’ 
23-25 
Cdx2 
 
578-600 
649-672 
250 5’-CCCAGCGGCCAGCGGCGAAACCT-3’ 
3’-TATTTGTCTTTTGTCCTGGTTTTC-5’ 
28 
TGFβ1 
 
731-752 
1415-1392 
661 5’-GAAGTCACCCGCGTGCTAATGG-3’ 
3’-GGATGTAAACCTCGGACCTGTGTG-5’ 
28 
TNFα 3033-3055 
3178-3155 
122 5’-TTCTGTGAAAACGGAGCTAAAC-3’ 
3’-TTTATTACGACTAAACCACTGGT-5’ 
37 
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Table II: 
Plasma urea and corticosterone concentrations in control, fasted and refed rats 
 
 Urea g.LP-1 P Corticosterone 10P-9 Pg.LP-1 P 
Ctrl 0.189 ± 0.007PaP 83.98 ± 61.06PaP 
   
P2r0 0.203 ± 0.011PaP 1077.42 ± 312.80Pab P 
P2r2 0.319 ± 0.025Pab P 51.90 ± 29.35PaP 
P2r6 0.282 ± 0.014Pab P 160.34 ± 72.61PaP 
P2r24 0.176 ± 0.015PaP 607.31 ± 243.19Pab P 
   
P3r0 0.708 ± 0.068Pb P 31101.09 ± 6269.80Pb P 
P3r2 0.598 ± 0.067Pb P 708.24 ± 175.74Pab P 
P3r6 0.448 ± 0.009Pab P 1467.44 ± 523.99Pab P 
P3r24 0.243 ± 0.017Pab P 678.42 ± 384.57Pab P 
 
Results are means ± SEM, n=6 rats per group. Within the same column, values with no letter 
in common are significantly different (P<0.05) 
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Figure legends 
 
Figure 1: ESEM (a to i) and CSEM (j to l) observations of the morphological apoptotic 
changes in the jejunal mucosa of control (a, j), phase II fasted (b, k), phase III fasted (c, l) rats 
and in refed rats 2h (d), 6h (e), 24h (f) after a phase II fast and 2h (g), 6h (h), 24h (i) after a 
phase III fast. V: villus, VT: villus tip, ZA: zone of apoptosis, MO: mucus orifice, VB: villus 
base, M: mucus, AC: apoptotic cell, MV: microvilli.  
 
Figure 2: Localization of TUNEL-positive cells in the jejunal mucosa of control (a), phase II 
(b) and phase III fasted (c) rats, and in refed rats 2h (d), 6h (e), 24h (f) after a phase II fast and 
2h (g), 6h (h), 24h (i) after a phase III fast. Bar=20µm. LP: lamina propria, E: epithelium, 
VT: villus tip, TP: TUNEL-positive nucleus, NS: non-specific labeling corresponding to red 
blood cells and immune cells. (j) Percentage of TUNEL-positive cells in intestinal villi. Mean 
+/- SEM (n=5 animals per group). Values with different letters were significantly different 
(P≤ 0.05). 
 
Figure 3: RT-PCR (A) and western blot (B) analysis of TNFα in Ctrl, P2r0 and P3r0 rats and 
after refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24). Mean +/- SEM (n=5 per group). 
Values with no letters in common were significantly different (P≤ 0.05). 
 
Figure 4: RT-PCR (A) and western blot (B) analysis of TGFβ1 in Ctrl, P2r0 and P3r0 rats and 
after refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24). Mean +/- SEM (n=5 per group). (C) 
TGFβ1 immunohistochemical localization in Ctrl, P2r0, P3r0, P2r2 and P3r2 rats. TGFβ1 is 
localized in the cytoplasm of intestinal epithelial cells and is mainly observed in the intestinal 
villi of control and refed animals (6h and 24h refeeding data not shown). 
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Figure 5: RT-PCR (A) and western blot (B) analysis of Cdx2 in Ctrl, P2r0 and P3r0 rats and 
after refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24). Mean +/- SEM (n=5 per group). (C) 
Cdx2 immunohistochemical localization in Ctrl, P2r0, P3r0, P2r2 and P3r2 rats. Cdx2 is 
located in the nuclei of intestinal cells and is weakly expressed in phase III fasting animals. 
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